Biodesix, Inc. (BDSX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Company Overview - Biodesix is a diagnostics company focused on developing tests to improve patient lives and outcomes, primarily in the area of lung cancer [1] - The company provides research services across various cancers and diseases, indicating a broad scope in research and development [1] Product Offerings - Biodesix has five tests available in the lung cancer market, all covered by Medicare [2] - Two of these tests are designed to identify patients likely to have malignant lung cancer, guiding them towards biopsy or surgery, while the other three tests help determine appropriate treatments for diagnosed patients [2]